Cite
HARVARD Citation
Alhaja, M. et al. (n.d.). Real-world tolerability of biosimilar bevacizumab-awwb compared to bevacizumab in patients with cancer at an academic medical center.. Journal of clinical oncology. 40 (28), p. 322. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Alhaja, M. et al. (n.d.). Real-world tolerability of biosimilar bevacizumab-awwb compared to bevacizumab in patients with cancer at an academic medical center.. Journal of clinical oncology. 40 (28), p. 322. [Online].